Abnormal bone marrow stem cells drive development of myelodysplastic syndromes
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes, serious blood diseases that are common among the elderly and that can progress to acute leukemia.
Japanese researchers recently found that high levels of the proteins survivin and aurora-B may be associated with disease progression in myelodysplastic syndromes.